In view of Tuesday’s FDA recommendation to suspend J & J’s one-shot vaccine use through this prism, Parikh said the temporary stalemate shows that regulatory “security controls and balances are working.”
“For now, I would be wary of any of these conspiracy theories and panic again,” said Parikh, a clinical assistant professor in the medical department of the NYU Grossman School of Medicine.
“You are much more likely to clot from the real Covid-19 virus, which sees around 1 in 20 people hospitalized or even 1 in 100 recovering at home. That is far more likely,” she added “Squawk on the street, “citing data from the industry group Thrombosis Canada.
Parikh’s comments came hours after the Food and Drug Administration and Centers for Disease Control and Prevention urged the states to temporarily suspend the administration J & J’s vaccine developed a rare but serious bleeding disorder after six women in the US who received it. One of the recipients died and another is in critical condition.
Almost 7 million people received the J&J shot. Apart from the six cases reported by the federal health authorities, no other cases are known. The J&J vaccine uses an adenovirus delivery system. Adenovirus is a common type of virus that typically causes mild cold symptoms.
When asked if J & J’s vaccine could still be given to Americans while investigating the six known blood clot cases, Parikh said it was best to stop them for now.
“They don’t revoke the emergency permit. They don’t say it’s a bad vaccine. Breaks are perfectly normal,” she said. “As we vaccinate more people – millions versus tens of thousands in clinical trials – those pauses will occur. I think they are the right step. That way we know for sure that it is safe to move forward.”
However, Parikh said that, on looking at the bigger picture, based on the information currently available, “the benefits still far outweigh the risks of this vaccination”.
The Chief Medical Officer of the White House, Dr. Anthony Fauci told reporters Tuesday there were no “red flag” signals from the two-shot vaccines Pfizer or Moderna. These two vaccines, the only other emergency approved in the US, use a new approach to vaccines that use genetic material to trigger an immune response.